Increasing patient access to faecal microbiota transplantation with remote delivery: a cost analysis of outpatient versus home-based treatment
Abstract Background Faecal microbiota transplantation (FMT) for recurrent Clostridioides difficile infection (CDI) is used in less than 10% of the patients in Europe who meet the indication. Encapsulated FMT allows increased use for CDI because capsules can be safely shipped to local healthcare faci...
שמור ב:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2025-11-01
|
| סדרה: | Health Economics Review |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s13561-025-00706-8 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
